Introduction

NPP100 Nandrolone Phenylpropionate2

musclepic 4

Products Description

#### **1. Pharmacological Properties and Clinical Advantages**

1. **Anabolic Effect**

As a testosterone derivative, NPP100 has an anabolic efficiency approximately 1.5 times that of testosterone, while exhibiting only 50% of its virilizing effect. This property allows it to promote protein synthesis and increase muscle mass while significantly reducing the risk of virilizing side effects (such as hirsutism and deepening of the voice), making it particularly suitable for the treatment of female patients.

2. **Joint Repair and Pain Relief**

Clinical studies have shown that NPP100 can stimulate collagen synthesis, enhance the toughness of joint cartilage, and alleviate the pain of chronic arthritis through its anti-inflammatory effects. Furthermore, it can increase bone density, which has positive benefits for patients with osteoporosis.

3. **Erythropoiesis Stimulation**

This drug can stimulate renal secretion of erythropoietin (EPO), increasing hematocrit, making it suitable for adjunctive treatment of anemia or enhancing endurance in athletes.

4. **Half-Life Advantage**

The phenylpropionate chain gives NPP a half-life of approximately 4-5 days, intermediate between the short-acting propionate and the long-acting decanoate. This property allows for two to three weekly injections, achieving a balance between maintaining blood stability and reducing injection frequency.

---

#### **2. Physical and Chemical Properties**

1. **Formulation Composition**

- **Active Ingredient**: Napproxol phenylpropionate (chemical formula C27H34O3), 100 mg per mL.

- **Solvent System**: Sesame oil or castor oil is typically used as a carrier, supplemented with benzyl alcohol (1-2%) as an antibacterial agent and viscosity modifier.

- **Antioxidant Design**: Some formulations contain vitamin E (tocopherol) to prevent oil oxidation and deterioration.

2. **Appearance and Stability**

- **Color**: Transparent, pale yellow to amber color, with the color depth varying depending on the type and purity of the oil used.

- **Viscosity**: Viscosity is approximately 50-70 cP at 25°C. A 21-23 gauge needle is required for intramuscular injection.

- **Storage Conditions**: It is recommended to store at 15-30°C away from light. Low temperatures may cause crystallization, which can be restored to homogeneity in a warm water bath.

3. **Compatibility Analysis**

It has good compatibility with most steroid oils (such as testosterone and drostanolone), but should be avoided with aqueous preparations to prevent demulsification.

---

#### **3. Application Scenarios and Risk Management**

1. **Medical Applications**

- **Cachexia Treatment**: For muscle atrophy caused by cancer and HIV infection. The recommended dosage is 1-2 mg per kilogram of body weight per week.

- **Burn Rehabilitation**: Accelerates wound healing by reversing negative nitrogen balance.

- **Gynecological Diseases**: Used in combination with estrogen to treat breast fibrosis, but dosage must be strictly controlled to prevent virilization.

2. **Sports Medicine Controversy**

Despite its significant strength and recovery improvements, NPP100 is listed as a banned substance by the World Anti-Doping Agency (WADA). Abuse may lead to dyslipidemia, increased cardiovascular stress, and pituitary-gonadal axis suppression.

3. **Risk Mitigation Strategies**

- **Cycled Use**: It is recommended that single cycles should not exceed 8 weeks, with a total annual dosage of less than 2 g.

- **Adjunctive Medications**: Use with SERMs (selective estrogen receptor modulators) such as tamoxifen to prevent breast hyperplasia.

- **Monitoring Indicators**: Regularly monitor liver function, lipoprotein profile, and prostate-specific antigen (PSA).

---

#### **Conclusion**

As a moderate-acting anabolic steroid, NPP100 offers both clinical value and practical advantages when used appropriately. Its light yellow oily form achieves a balance of efficacy and stability through precise formulation design, but strict medical oversight is required to mitigate endocrine disruption and metabolic risks. Future directions for dosage form improvements include nanoemulsification technology (to reduce injection pain) and transdermal delivery systems (to improve medication compliance), in order to expand the boundaries of treatment while controlling risks.